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Abstract  
 The functional correlation of missense mutations which cause disease remains a challenge to understanding 
the basis of genetic diseases. This is particularly true for proteins related to diseases for which there are no 
available three dimensional structures. One such disease is Shwachman Diamond syndrome SDS OMIM 
260400, a multi system disease arising from loss of functional mutations. The Homo sapiens Shwachman 
Bodian Diamond Syndrome gene hSBDS is responsible for SDS. hSBDS is expressed in all tissues and encodes 
a protein of 250 amino acids SwissProt accession code Q9Y3A5. Sequence analysis of
 
disease associated alleles 
has identified more than 20 different
 
mutations in affected individuals. While a number of these mutations 
have been described as leading to the loss of protein function due to truncation, translation or surface epitope 
association, the structural basis for these mutations has yet to be determined due to the lack of a three-
dimensional structure for SBDS.  Moreover, SBDS is a highly conserved gene of unknown function, however, 
biochemical studies suggest that SBDS may be involved in RNA metabolism or ribosome assembly. Here, we 
describe a homology model for hSBDS which is based on the crystal structure of AF0491 from Archaeoglobus 
fulgidus PDB code  1P9Q that shares 24 percent  sequence identity and 49 percent similarity with hSBDS. 
This model provides insights into how the different mutations are involved in translation, truncation, protein 
protein interactions, protein stability and function.  
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1. 1INTRODUCTION 
 Structural proteomics (SP) is a global and rapidly 
growing research domain following the recent 
successes in genome sequencing and technical 
breakthroughs in macromolecular crystallography (MX) 
and nuclear magnetic resonance (NMR) [1]. MX is a 
very powerful technique allowing the structures of 
proteins, nucleic acids and their complexes to be 
determined at atomic resolution. Worldwide SP 
initiatives have developed and implemented 
technologies that facilitate automated, high-throughput 
three-dimensional protein structure determination [2]. 
The main focus of these initiatives is to determine the 
structures of a diverse set of proteins which span as 
many protein families as possible. With the advent of 
advances in protein structure analysis, experimentally 
determined three-dimensional structures of 
representative members of large protein families are 
being generated at an ever increasing pace. For 
example, the protein structure initiative (PSI) produced 
over 1,300 structures during its pilot phase (year 2000-
2005) and, to date, approximately 3,000 structures have 
already been deposited in the protein data bank 
(PDB)[3]  during the second phase (year 2006-2010). 
This success is also evident in the increased 
contribution from other world-wide SG/SP centers in 
terms of the number of structures being deposited into 
the PDB [4]. 
 Increased structural coverage of protein families 
with high biomedical importance enables the 
exploration of structure-function relationships and aides 
computational modeling. Homology modeling is a 
powerful technique that greatly enhances the value of 
experimentally determined structures by using the 
structural information from one protein to predict the 
structures of related proteins. Protein families in which 
at least one experimental structure has been determined 
can act as a template for modeling other family 
members (provided the level of sequence identity is at 
least 25%). Current methodologies and technologies for 
homology modeling can produce structural models with 
highly accurate backbones and an intermediate level of 
accuracy for side chains and loops [5,6,7]. Given that 
the number of experimental structures available is far 
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lower than the huge number of sequenced proteins, high 
quality models can be produced for a proportion of 
these proteins of unknown structure and reliable models 
can be generated for up to 60% of the remaining 
proteins encoded by a particular genome. Homology 
modeling plays an important role in filling the huge gap 
between experimentally determined structures and 
sequenced proteins, especially for the structures of 
proteins related to human diseases which prove difficult 
to determine experimentally. Thus, the vast majority of 
biologists are increasingly reliant on homology models 
of proteins of interest. Additionally, the protein 
structures of disease-related proteins, experimental or 
predicted, are of great research interest to both 
experimental and computational biologists. Their high 
value in medicine and human health stems from the fact 
that they provide informative clues as to how they 
function in the cell and a molecular snapshot of the 
disease process which aides rational drug design [8]. 
This is particularly true for diseases caused by 
alterations of proteins for which no three-dimensional 
structure is available. With the help of homology 
modeling, disease-related mutations can also be studied 
at the atomic level. To date, thousands of proteins have 
been implicated in various human diseases. Frequently, 
mutations in these proteins have been identified in 
patients suffering from a particular disease. Mutational 
data often allows these diseases to be studied at the 
molecular level by generating the protein structure 
either through experimental procedures or by homology 
modeling.  
 In this report, a homology model for the Homo 
sapiens Shwachman-Bodian-Diamond Syndrome 
(hSBDS) gene is presented. SBDS is responsible for 
Shwachman-Diamond syndrome (SDS; OMIM 
260400), a multi-system disease arising from loss-of-
function mutations [9]. SDS is a rare autosomal 
recessive marrow failure syndrome associated with 
exocrine pancreatic insufficiency and leukemia 
predisposition. Bone marrow failure typically manifests 
with neutropenia, but anemia, thrombocytopenia, or 
aplastic anemia may also develop. Other clinical 
features include skeletal, immunologic, hepatic and 
cardiac disorders [9-12].  
 The SBDS gene is ubiquitously expressed and 
encodes a protein of 250 residues (SwissProt accession 
code Q9Y3A5). The function of this protein is unknown 
and it has no primary sequence similarity to any other 
protein or structural domain that could indicate a 
possible function. However, biochemical studies 
suggest that SBDS protein may be involved in RNA 
metabolism or ribosome assembly. Many of the 
disease-associated mutations and truncations have also 
been identified. The model presented here may serve as 
a valuable reference to improve the understanding of 
the molecular basis of this disease and to provide a 
detailed view of the disease-related mutations within 
the structural domains of the protein.  
 
2. MATERIALS AND METHODS 
 Template Search and Sequence Alignment: The 
protein sequence of Shwachman-Bodian-Diamond 
syndrome (Accession no. AAN77490) of Homo sapiens 
was retrieved from the NCBI database. A Basic Local 
Alignment Search Tool (BLAST) [13] search was 
performed against the Protein Data Bank (PDB) [14] 
using default parameters to find suitable templates for 
homology modeling. Based on the maximum identity 
with high score and low e-value, 1P9Q at 2.0 Å 
resolution was selected as the most appropriate 
template for homology modeling. The sequence identity 
and similarity are 24% and 49% between the template 
(1P9Q) and the target sequence respectively. The 
Clustal-W (http://www.ebi.ac.uk/clustalw) [15] 
program was used to produce the sequence alignment 
between hSBDS and 1P9Q. 
 3D Structure Generation: The academic version of 
MODELER (http//:www.salilab.org/modeler) [16] was 
used for three-dimensional structure generation based 
on the information obtained from the sequence 
alignment. Out of 20 models generated by 
MODELLER, the one with the best G-score in 
PROCHECK [17] and the best VERIFY3D [18] profile 
was subjected to energy minimization. Using the 
parameters as a distance-dependent dielectric constant 
  = 1.0 and non-binding cutoff of 14 Å, CHARMM 
[19] force field and CHARMM-all-atom charges, 
initially a 600 step steepest descent algorithm was used 
to remove close Van der Waals contacts, followed by 
an 800 iteration conjugate gradient minimization until 
the energy showed stability in sequential repetition. All 
hydrogen atoms were included during the calculation. 
The energy minimization described above was started 
with the core main chain and then extended to all the 
core side chains. All calculations were performed using 
the ACCELRYS DS Modeling 2.0 (Accelrys Inc. San 
Diego, CA 92121, USA) software suite. During these 
steps, the quality of the initial model improved 
significantly. STRIDE [20], which uses hydrogen bond 
energy and main chain dihedral angles to recognize 
helix, coils and strands, was subsequently used to 
predict the secondary structure composition of the 
modeled SBDS. The weighted root mean square 
deviation (RMSD) of the modeled protein was 
calculated using the combinatorial extension (CE) 
algorithm [21]. The modeled structure was then 
superimposed on the crystal template without altering 
the coordinate systems of atomic position in the 
template. The RMSD for the superimposition is 2.1Å. 
The residue profiles of the three-dimensional models 
were further checked using VERIFY3D [18]. 
                                                                                   InterJRI Science and Technology, Vol. 1, Issue 2, July 2009                                                                
 
 
85 
PROCHECK [17] analysis was performed in order to 
assess the stereo-chemical properties of the three-
dimensional models and Ramachandran plots were 
calculated. No residues reside in the disallowed regions 
of the Ramachandran plot. 
 
3. RESULTS AND DISCUSSION 
Homology Model 
 The X-ray structure of an SBDS homologue in 
Archaeoglobus fulgidus, AF0491 [22], was used as the 
structural template (PDB 1P9Q) for the homology 
modeling protocol. The sequence alignment between 
human SBDS (hSBDS) and Archaeoglobus fulgidus 
AF0491 (AfSBDS) is shown in Figure 1. All conserved 
residues are coloured grey. The alignment is 
characterized by some insertions and deletions in loop 
regions. Since the first 9 N-terminal residues and the 
last 9 C-terminal residues (residues 241–250) in SBDS 
do not have corresponding residues in 1P9Q, the 
modeling was carried out from residues 10-240, 
followed by a rigorous refinement of the model by 
means of Energy Minimization (EM - see the Materials 
and Methods section for the protocol used). The three-
dimensional conformation of the predicted model of 
SBDS is presented in Figure 2. The stereo-chemical 
quality of the modeled SBDS was evaluated using 
PROCHECK. The main chain phi/psi angles for 94.9% 
of residues fall in the most favored regions, 4.7% of 
residues lie in the additionally allowed regions and 
0.5% fall in the generously allowed regions. No 
residues are present in unfavourable regions of the 
Ramachandran plot (Figure 3). The overall 
PROCHECK G-factor for the homology modeled 
structure was – 0.05. Thus, statistical analysis suggests 
that the backbone conformation of the predicted model 
of SBDS is almost as good as that of the template. 
VERIFY3D provided the plot which indicates that the 
final protein model is correct. The secondary structure 
elements of SBDS were predicted using the program 
STRIDE, which uses hydrogen bond energy and main 
chain dihedral angles to recognize helix, coils and 
strands which are well defined in the modeled SBDS 
structure.  
 
Overall Structure 
 The core features of the three dimensional SBDS 
homolog (AfSBDS) structure are retained in the hSBDS 
model (Figure 2)[22, 23]. The subunit structure of 
hSBDS is organized into three domains: an N-terminal, 
central and C-terminal domain. The N-terminal domain 
was first identified in the AfSBDS structure and 
displayed no structural similarity to other protein folds 
in the PDB. Therefore, this domain represented a novel 
fold and was termed the Fungal, Yhr087wp, 
Shwachman domain (FYSH). The central domain 
comprises -helices arranged in helix-turn-helix motifs 
suitable for RNA or DNA binding [24]. The C-terminal 
domain resembles a ferrodoxin-like fold which 
commonly exists in a large number of proteins [25].  
The structural superposition of the Cα atom positions of 
the hSBDS homology model and SfSBDS (Figure 4) 
gives an RMSD of 2.1Å with a significant Z-score of 
6.8.  Structural differences stretching throughout the 
model represent conformational flexibility between the 
homologues.  
 
Implications for SDS  
 The wide occurrence of SBDS homologues 
provides opportunities to glean insights into the 
molecular basis of this disease [26]. The structure of 
AfSBDS was recently determined and indicated that the 
tertiary structure of this protein is arranged in three 
domains, comprising a novel N-terminal FYSH domain 
followed by two domains that are highly conserved in 
other structural domains [22,23,26]. On the other hand, 
biophysical and biochemical functional data from 
model organisms clearly provides clues to functional 
conservation in family members and a phylogeny study 
reveals that the characteristics of a functionally 
coherent group of SBDS proteins is highly suggestive 
of a role in translation and/or RNA metabolism [27]. 
The structural and functional analyses of SBDS 
orthologues, coupled to its localization within the 
nucleus, suggest an involvement in RNA processing 
[22,28].    
 More than 20 mutations have been identified in 
hSBDS which are highlighted in reverse type in Figure 
1. The functional consequences of SBDS mutations 
have not yet been characterized, however, mutations in 
the affected patients result from gene conversion 
between SBDS and an SBDSP pseudogene [29]. Most 
mutations are present in the N-terminal FYSH of 
hSBDS suggesting that this domain plays an important 
physiological role. The most important point mutation, 
C31W, is located within the hydrophobic core of the 
FYSH domain (Figure 5). Strikingly, C31 has the 
potential to form a disulfide bond with another mutated 
residue, C84, to enhance structural stability. The 
structural consequences of the dual C31 and C84 
mutations will be to destabilize the protein which will 
adversely affect protein function.  Therefore, these 
mutations are responsible for protein stability and will 
eventually cause SDS.  
A detailed understanding of the functions of hSBDS is 
not known, however, based on the structural features 
identified in the modeled structure, one can speculate 
potential roles. In this regard, residues located on the 
surface of SBDS proteins are likely to be important for 
interacting with partner proteins and any mutation of 
these residues will affect the surface electrostatic 
potential. Some of the missense mutations such as 
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E44G, K118N, E28A and R100A, which are implicated 
in SDS disease, are localized on the surface of hSBDS 
and have been mapped onto the modeled structure 
(Figure 6). Based on proteomics data, an SBDS-
interactome has been developed and SBDS binding 
partners with diverse molecular functions, notably 
components of the large ribosomal subunit and proteins 
involved in DNA metabolism, have been reported [30]. 
The in-depth comparison of experimental data with the 
structural data will provide further insights into SDS.  
 
4. CONCLUSION  
 To date, thousands of genes (proteins) have been 
identified to be associated with various human diseases. 
Frequently, mutations in these proteins have been 
identified in patients suffering from a particular disease. 
Homology modeling is a valuable tool to help to 
understand how these mutations cause disease. Here, a 
homology model of hSBDS has been generated using a 
bioinformatics approach. Our analysis provides insights 
into the distribution of the mutations implicated in SDS 
and highlights how they can influence protein stability 
and alter the surface electrostatic potential.  We plan to 
extend the current study to the prediction of the 
structures of complexes of disease proteins. The 
resulting complex models would provide an important 
resource for studying the mechanism of disease. 
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 hSBDS MSIFTPTNQI RLTNVAVVRM KRAGKRFEIA CYKNKVVGWR SGVEKDLDEV 50 
SfSBDS --------MV SLDKAVIARL RKGGEEFEVL VDPYLARDLK EGKEVNFEDL 42 
            
 hSBDS LQTHSVFVNV SKGQVAKKED LISAFGTDDQ TEICKQILTK GEVQVSDKER 100  
SfSBDS LAAEEVFKDA KKGERASVDE LRKIFGTDDV FEIARKIILE GEVQITAEQR 92 
hSBDS HTQLEQMFRD IATIVADKCV NPETKRPYTV ILIERAMKDI HYSVKTNKST 150  
SfSBDS REMLEAKRKQ IINFISRNTI DPRTNAPHPP SRIERALEEA KVHIDIFKSV 142  
     
hSBDS KQQALEVIKQ LKEKMKIERA HMRLRFILPV NEGKKLKEKL KPLIKVIESE 200  
SfSBDS EAQVKDIVKA LKPILPLKFE EMEIAIKIPP EHTGRAISAL YNFGGVTR-E 191  
hSBDS DYGQQLEIVC LIDP--GCFR EIDELIKKET KGKGSLEVLN LKDVEEGDEK FE 250  
SfSBDS EWQRDGSWIC VMRIPSGMYG DLMDLLGKVA KGEALTKVLR RIG------- -- 234 
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Figure 1. Sequence Alignment between Human SBDS (hSBDS) and AfSBDS. Identical residues are highlighted in 
grey (total of 24% identity). The positions of the human SBDS-associated mutations are highlighted in reverse type. 
 
 
Figure 2. Schematic representation of the modeled SBDS structure. Figure prepared using the 
program PyMOL. 
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Figure 3. Ramachandran plot for the hSBDS model. 
 
 
 
Figure 4. C trace of the hSBDS model (dark blue) superposed on  
AfSBDS (light blue). Figure prepared using the program PyMOL. 
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Figure 5. The key point mutation, C31W, is located within the hydrophobic core of the FYSH 
domain and resides within close proximity to C84 
 
 
 
Figure 6. Some of the surface localized mutations involved in interactions highlighted in cyan 
 
